Citius Pharmaceuticals, Inc. (CTXR) Reports Q1 Loss of $0.06
Tweet
Share
E-mailGet Alerts CTXR Hot Sheet
Join SI Premium – FREE
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) reported Q1 EPS of ($0.06).
For earnings history and earnings-related data on Citius Pharmaceuticals, Inc. (CTXR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- RBC Capital Downgrades GQG Partners Inc (GQG:AU) to Sector Perform
- Danske Bank A/S (DANSKE:DC) (DNKEY) PT Raised to DKK436 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
Citi, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
